In conclusion, it is unclear whether HIIT influences levels of MMP in breast cancer patients undergoing anthracycline-based chemotherapy yet MMP-2 was significantly increased both the HIIT and CON group; with no changes on MMP-1, -7, -10, TIMP-1 and -2. This evidence concerns the gene MMP1 and breast carcinoma.